Cell-free DNA (cfDNA) can act as a powerful biomarker for cancer research, from disease onset to therapy selection and minimal residual disease (MRD) measurement. Next-generation sequencing (NGS) has ...
The selection of diverse versus targeted compound libraries shapes the balance between exploring novel chemical space and interrogating known biological targets. The diversity-oriented vs focused ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results